Search research articles
Contact Us
Filters
Showing results (71-80 of 174) with videos related to
Page
of 18
Sort By:
The Lancet. Neurology
|
May 2, 2021
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B Frisoni, et al.
The Lancet. Neurology
|
February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling, Stephen Salloway, David J Brooks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 25, 2024
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies
Pierre N Tariot, Marie-Emmanuelle Riviere, Stephen Salloway, et al.
Nature Medicine
|
March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial
Catherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
JAMA
|
July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
John R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
An International Journal on Information Fusion
|
April 15, 2020
Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning
Diego Castillo-Barnes, Li Su, Javier Ramírez, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
JAMA Neurology
|
March 10, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials
Jennifer A Zimmer, Paul Ardayfio, Hong Wang, et al.
Brain : a Journal of Neurology
|
February 18, 2015
Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network
John M Ringman, Li-Jung Liang, Yan Zhou, et al.
The New England Journal of Medicine
|
January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
Stephen Salloway, Reisa Sperling, Nick C Fox, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 174) with videos related to
Sort By:
Page
of 18
The Lancet. Neurology
|
May 2, 2021
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B Frisoni, et al.
The Lancet. Neurology
|
February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling, Stephen Salloway, David J Brooks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 25, 2024
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies
Pierre N Tariot, Marie-Emmanuelle Riviere, Stephen Salloway, et al.
Nature Medicine
|
March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial
Catherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
JAMA
|
July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
John R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
An International Journal on Information Fusion
|
April 15, 2020
Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning
Diego Castillo-Barnes, Li Su, Javier Ramírez, et al.
Dementia and Geriatric Cognitive Disorders
|
August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
JAMA Neurology
|
March 10, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials
Jennifer A Zimmer, Paul Ardayfio, Hong Wang, et al.
Brain : a Journal of Neurology
|
February 18, 2015
Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network
John M Ringman, Li-Jung Liang, Yan Zhou, et al.
The New England Journal of Medicine
|
January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
Stephen Salloway, Reisa Sperling, Nick C Fox, et al.
Page
of 18